IP Verse

Endocyte, Inc. V. Point Biopharma Global Inc. - 1:24-cv-01011

Endocyte, Inc. V. Point Biopharma Global Inc. (Case No. 1:24-cv-01011), filed on Jun 13, 2024 in the District Court, S.D. Indiana involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:24-cv-01011
Filing Date
Jun 13, 2024
Cause of Action
Patent Infringement
Status
-
Court
District Court, S.D. Indiana
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
POINT BIOPHARMA INC. -
NOVARTIS PHARMACEUTICAL CORPORATION -
ELI LILLY AND CO. -
PURDUE RESEARCH FOUNDATION -
ENDOCYTE, INC. -

Patents Involved

There is a single patent involved in this case.

Application NumberPatent Number
-US10624970B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Mar 28, 2025ORDER GRANTING MOTION TO CONTINUE AND RESET TELEPHONIC STATUS CONFERENCE - This matter is before the Court on Defendants' Consent Motion for Continuance of Telephonic Status Conference, and the Court being duly advised, hereby grants the motion. [Filing No. 60 .] IT IS THEREFORE ORDERED that the telephonic status conference currently set for April 8, 2025, is vacated and reset for 2:30 p.m. (Eastern Time) on April 22, 2025. The information needed by counsel of record to participate in this telephonic conference will be provided by separate notification. The purpose of this conference is to address case status and settlement. Three business days prior to the telephonic status conference, the parties shall confer and file a proposed Case Management Plan, which can be found on the Court's website at www.insd.uscourts.gov, addressing any remaining discovery needs, trial readiness, and the timing of a settlement conference Signed by Magistrate Judge Tim A. Baker on 03/28/2025. (AJG) (Entered: 03/28/2025)PACER Document
Apr 1, 2025ORDER granting 62 Motion to Appear pro hac vice. Attorney Eric W. Dittmann for ELI LILLY AND CO., POINT BIOPHARMA GLOBAL INC., POINT BIOPHARMA INC. added. Counsel shall register for electronic filing, as required by Local Rule 5-3, within 7 days. Signed by Magistrate Judge Tim A. Baker on 4/1/2025 (Copy mailed to Eric W. Dittmann). (LBT) (Entered: 04/01/2025)PACER Document
Apr 1, 2025ORDER granting 61 Motion to Appear pro hac vice. Attorney Bruce M. Wexler for ELI LILLY AND CO., POINT BIOPHARMA GLOBAL INC., and POINT BIOPHARMA INC. added. Counsel shall register for electronic filing, as required by Local Rule 5-3, within 7 days. Signed by Magistrate Judge Tim A. Baker on 4/1/2025 (Copy mailed to Bruce M. Wexler). (LBT) (Entered: 04/01/2025)PACER Document
Apr 1, 2025ORDER granting 63 Motion to Appear pro hac vice. Attorney Candace Polster for ELI LILLY AND CO., POINT BIOPHARMA GLOBAL INC., POINT BIOPHARMA INC. added. Counsel shall register for electronic filing, as required by Local Rule 5-3, within 7 days. Signed by Magistrate Judge Tim A. Baker on 4/1/2025 (Copy mailed to Candace Polster). (LBT) (Entered: 04/01/2025)PACER Document
Apr 2, 2025Consent MOTION for Extension of Time to April 25, 2025 for Defendants' to Answer Plaintiffs' Complaint and for Plaintiffs' to Respond Thereto, filed by Defendants ELI LILLY AND CO., POINT BIOPHARMA GLOBAL INC., POINT BIOPHARMA INC.. (Attachments: # 1 Text of Proposed Order)(McKenna, William) (Entered: 04/02/2025)PACER Document
Apr 3, 2025ORDER granting 68 MOTION FOR EXTENSION OF TIME FOR DEFENDANTS TO ANSWER PLAINTIFFS' COMPLAINT AND FOR PLAINTIFFS TO RESPOND THERETO: IT IS THEREFORE ORDERED that Defendants' answer is now due April 25, 2025 and Plaintiffs' response thereto, if any, is now due May 23, 2025. See Order. Signed by Magistrate Judge Tim A. Baker on 4/3/2025. (LF) (Entered: 04/03/2025)PACER Document
Apr 17, 2025Submission ESI Supplement to Case Management Plan, filed by Plaintiff NOVARTIS PHARMACEUTICAL CORPORATION. (Hidde, Kandi) (Entered: 04/17/2025)PACER Document
Apr 17, 2025CASE MANAGEMENT PLAN TENDERED, filed by Plaintiff NOVARTIS PHARMACEUTICAL CORPORATION . (Hidde, Kandi) (Entered: 04/17/2025)PACER Document
Apr 23, 2025ORDER: PATENT CASE MANAGEMENT PLAN - Dispositive Motions due by 8/26/2026. Discovery due by 2/6/2026. Status Conference set for 9/23/2025 01:30 PM in Telephonic before Magistrate Judge Tim A. Baker. Approved and So Ordered. Signed by Magistrate Judge Tim A. Baker on 4/23/2025.(KAA) (Entered: 04/23/2025)PACER Document
Apr 25, 2025DEFENDANTS' ANSWER to 1 Complaint, COUNTERCLAIM against All Plaintiffs, filed by All Defendants. (Attachments: # 1 Supplement, # 2 Exhibit, # 3 Exhibit, # 4 Exhibit, # 5 Exhibit, # 6 Exhibit, # 7 Exhibit, # 8 Exhibit, # 9 Exhibit, # 10 Exhibit)(Polster, Candace) (Entered: 04/25/2025)PACER Document
May 15, 2025NOTICE of Answer in lawsuit sent to Director of U.S. Patent and Trademark Office. (Attachments: # 1 Answer) (AJG) (Entered: 05/15/2025)PACER Document
May 16, 2025ANSWER to 74 Answer to ComplaintCounterclaim, filed by All Plaintiffs.(Hidde, Kandi) (Entered: 05/16/2025)PACER Document
Jun 13, 2024COMPLAINT against All Defendants, filed by All Plaintiffs. (Filing fee $405, receipt number AINSDC-8206974) (Attachments: # 1 Civil Cover Sheet, # 2 Proposed Summons, # 3 Exhibit A -10,624,970 Patent Certified, # 4 Exhibit B Nov 11, 2022 POINT-Lantheus Agreement)(Hidde, Kandi) (Entered: 06/13/2024)Attachment
Jun 13, 2024COMPLAINT against All Defendants, filed by All Plaintiffs. (Filing fee $405, receipt number AINSDC-8206974) (Attachments: # 1 Civil Cover Sheet, # 2 Proposed Summons, # 3 Exhibit A -10,624,970 Patent Certified, # 4 Exhibit B Nov 11, 2022 POINT-Lantheus Agreement)(Hidde, Kandi) (Entered: 06/13/2024)Attachment
Jun 13, 2024COMPLAINT against All Defendants, filed by All Plaintiffs. (Filing fee $405, receipt number AINSDC-8206974) (Attachments: # 1 Civil Cover Sheet, # 2 Proposed Summons, # 3 Exhibit A -10,624,970 Patent Certified, # 4 Exhibit B Nov 11, 2022 POINT-Lantheus Agreement)(Hidde, Kandi) (Entered: 06/13/2024)Attachment
Jun 13, 2024COMPLAINT against All Defendants, filed by All Plaintiffs. (Filing fee $405, receipt number AINSDC-8206974) (Attachments: # 1 Civil Cover Sheet, # 2 Proposed Summons, # 3 Exhibit A -10,624,970 Patent Certified, # 4 Exhibit B Nov 11, 2022 POINT-Lantheus Agreement)(Hidde, Kandi) (Entered: 06/13/2024)Attachment